Publication Cover
Natural Product Research
Formerly Natural Product Letters
Volume 36, 2022 - Issue 5
606
Views
5
CrossRef citations to date
0
Altmetric
Short Communication

Evaluation of anticholinesterase effect of some Epilobium species and quantification of hyperoside by HPLC

, , , , , , , , , , , & show all
Pages 1296-1299 | Received 05 Oct 2020, Accepted 23 Nov 2020, Published online: 11 Dec 2020
 

Abstract

This article presents the evaluation of anticholinesterase effects of aerial parts of Epilobium angustifolium, E. stevenii and E. hirsutum and isolated flavonoids from E. angustifolium, and quantification of the flavonoids by HPLC. Besides, the highest acetylcholinesterase inhibition was seen in the EtOAc sub-extracts of E. angustifolium and E. stevenii (36.51 ± 1.88 and 39.89 ± 3.09%, respectively), whereas EtOAc sub-extract of E. angustifolium had the best butyrylcholinesterase inhibition (62.09 ± 1.98%). Hyperoside showed strong inhibition activity on both enzymes. The active EtOAc sub-extract of E. angustifolium was quantitatively analyzed for their content of hyperoside (quercetin-3-O-β-D-galactoside) by HPLC. The content of hyperoside in EtOAc sub-extract of E. angustifolium was detected as 3.312%. The anatomical structures of the stem, leaf, sepal, petal, anther, and filament of E. angustifolium were investigated. The anatomical properties given in this study provide a description of E. angustifolium.

Acknowledgement

The authors thank Prof. Dr. Hayri Duman for his worthwhile support for diagnosing of plant materials. Bilge Aydin and Benan Dursunoglu would like to acknowledge the scholarship during her postgraduate program provided by the Turkish Scientific and Technical Research Council (TUBITAK).

Disclosure statement

No potential conflict of interest was reported by the authors.

Additional information

Funding

This paper was supported by Scientific Research Projects of Atatürk University (TCD-2018-6674).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.